LATAM Q1 Sales: Mexico's Genomma And Brazil's Hypera Report Gains
Executive Summary
Genomma Lab reports OTC sales rise in Q1 thanks to gains in its LATAM region, while Brazil's Hypera posts big jump in turnover due to acquisitions.
Topics
- Subjects
- Sales & Earnings
- Dietary Supplements
- OTC Drugs
- Regions
- North America
- South America
- Consumer Market Area
- Health
- Wellness
- Industries
- Consumer
Latest Headlines
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
RS151300
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
RS151300
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.